首页 > 最新文献

Sexual Medicine最新文献

英文 中文
Cannabis for female orgasmic disorder/difficulty: a systematic review. 大麻治疗女性性高潮障碍/困难:系统综述。
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-12 eCollection Date: 2025-08-01 DOI: 10.1093/sexmed/qfaf061
Suzanne Mulvehill, Jordan Tishler
<p><strong>Background: </strong>Cannabis is increasingly recommended to treat female orgasmic disorder/difficulty (FOD/difficulty), a condition that affects up to 41% of women worldwide with no conventional medications.</p><p><strong>Aim: </strong>To systematically review the existing literature on cannabis and its impact on female orgasm function.</p><p><strong>Methods: </strong>A systematic review based on the PRISMA model evaluated the effects of cannabis on orgasm function in females with or without FOD/difficulty. Risk of bias was assessed for randomized and nonrandomized studies. Searches were conducted in PubMed, Google Scholar, Cochrane, and Embase.</p><p><strong>Outcomes: </strong>Primary outcomes focused on the impact of cannabis on female orgasm function.</p><p><strong>Results: </strong>Sixteen studies met inclusion criteria: 1 randomized controlled trial and 15 observational studies, including data from 8849 females. Most were nonrandomized designs without comparator groups and high risk of bias. Most included both sexes and reported dichotomized outcomes by sex. None excluded females with self-reported orgasm difficulty; 1 controlled for its prevalence; 1 dichotomized females by the presence or absence of orgasm difficulty; and no studies used a clinical diagnosis of FOD. Nine studies investigated cannabis use prior to sexual activity. All 9 studies cited improvements in female orgasm function, including increases in frequency, ease, intensity, quality, and/or multiorgasmic capacity. However, 1 study found cases of situational anorgasmia, and 1 reported that women had more difficulty with focus, potentially leading to orgasm difficulty. Two studies assessed general cannabis use and sexual function: 1 found no association between the frequency of cannabis use and female sexual problems, while the other noted improved orgasm and reduced dysfunction with more frequent use. Five studies examined cannabis alongside other substances, before sex or not: 1 linked inhibited orgasm to combined cannabis and alcohol use, 1 to noncannabis substances, 2 found improved orgasm function with cannabis, and 1 reported improved orgasm function and cases of inability to orgasm due to a lack of focus.</p><p><strong>Clinical implications: </strong>Cannabis appears to be a promising treatment option for FOD/difficulty.</p><p><strong>Strengths and limitations: </strong>This review found consistent evidence that cannabis improves orgasm function in females with or without FOD/difficulty. Limitations include insufficient high-quality studies and limited reporting on cannabis dosage and timing.</p><p><strong>Conclusion: </strong>FOD/difficulty should be recognized as a qualifying condition for medical cannabis use. Given the existing evidence supporting its potential efficacy, medical cannabis warrants consideration as a first-line treatment. More randomized controlled trials are needed to clarify optimal dosing, routes of administration, strain specificity, ti
背景:大麻越来越多地被推荐用于治疗女性性高潮障碍/困难(FOD/困难),这一疾病影响着全世界多达41%的没有常规药物治疗的女性。目的:对大麻及其对女性性高潮功能影响的文献进行系统综述。方法:基于PRISMA模型系统评价大麻对有或无FOD/困难女性性高潮功能的影响。对随机和非随机研究进行偏倚风险评估。检索在PubMed, b谷歌Scholar, Cochrane和Embase中进行。结果:主要结果集中于大麻对女性性高潮功能的影响。结果:16项研究符合纳入标准:1项随机对照试验和15项观察性研究,包括8849名女性的数据。大多数是没有比较组和高偏倚风险的非随机设计。大多数包括两性,并报告了按性别划分的结果。没有排除自我报告性高潮困难的女性;1控制其流行程度;1通过存在或不存在性高潮困难来区分女性;没有研究使用FOD的临床诊断。9项研究调查了性行为前的大麻使用情况。所有9项研究都提到了女性性高潮功能的改善,包括频率、放松程度、强度、质量和/或多重高潮能力的提高。然而,一项研究发现了情境性无性高潮的案例,并报告说女性更难集中注意力,这可能会导致性高潮困难。两项研究评估了大麻的一般使用和性功能:一项研究发现大麻使用频率与女性性问题之间没有关联,而另一项研究则指出,更频繁地使用大麻可以改善性高潮,减少性功能障碍。五项研究将大麻和其他物质一起,在性行为前或不性行为前进行了检查:一项研究将抑制性高潮与大麻和酒精的结合使用联系起来,一项研究与非大麻物质有关,两项研究发现大麻可以改善性高潮功能,一项研究报告了性高潮功能的改善,以及由于缺乏注意力而无法达到性高潮的情况。临床意义:大麻似乎是FOD/困难的一种有希望的治疗选择。优势和局限性:本综述发现一致的证据表明,大麻可以改善有或没有FOD/困难的女性的性高潮功能。限制包括缺乏高质量的研究和关于大麻剂量和时间的有限报告。结论:应将FOD/困难视为医用大麻使用的合格条件。鉴于现有证据支持其潜在功效,医用大麻值得考虑作为一线治疗手段。需要更多的随机对照试验来阐明最佳剂量、给药途径、菌株特异性、使用时间以及不同FOD亚型的不同效果。
{"title":"Cannabis for female orgasmic disorder/difficulty: a systematic review.","authors":"Suzanne Mulvehill, Jordan Tishler","doi":"10.1093/sexmed/qfaf061","DOIUrl":"10.1093/sexmed/qfaf061","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Cannabis is increasingly recommended to treat female orgasmic disorder/difficulty (FOD/difficulty), a condition that affects up to 41% of women worldwide with no conventional medications.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Aim: &lt;/strong&gt;To systematically review the existing literature on cannabis and its impact on female orgasm function.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A systematic review based on the PRISMA model evaluated the effects of cannabis on orgasm function in females with or without FOD/difficulty. Risk of bias was assessed for randomized and nonrandomized studies. Searches were conducted in PubMed, Google Scholar, Cochrane, and Embase.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Outcomes: &lt;/strong&gt;Primary outcomes focused on the impact of cannabis on female orgasm function.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Sixteen studies met inclusion criteria: 1 randomized controlled trial and 15 observational studies, including data from 8849 females. Most were nonrandomized designs without comparator groups and high risk of bias. Most included both sexes and reported dichotomized outcomes by sex. None excluded females with self-reported orgasm difficulty; 1 controlled for its prevalence; 1 dichotomized females by the presence or absence of orgasm difficulty; and no studies used a clinical diagnosis of FOD. Nine studies investigated cannabis use prior to sexual activity. All 9 studies cited improvements in female orgasm function, including increases in frequency, ease, intensity, quality, and/or multiorgasmic capacity. However, 1 study found cases of situational anorgasmia, and 1 reported that women had more difficulty with focus, potentially leading to orgasm difficulty. Two studies assessed general cannabis use and sexual function: 1 found no association between the frequency of cannabis use and female sexual problems, while the other noted improved orgasm and reduced dysfunction with more frequent use. Five studies examined cannabis alongside other substances, before sex or not: 1 linked inhibited orgasm to combined cannabis and alcohol use, 1 to noncannabis substances, 2 found improved orgasm function with cannabis, and 1 reported improved orgasm function and cases of inability to orgasm due to a lack of focus.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Clinical implications: &lt;/strong&gt;Cannabis appears to be a promising treatment option for FOD/difficulty.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Strengths and limitations: &lt;/strong&gt;This review found consistent evidence that cannabis improves orgasm function in females with or without FOD/difficulty. Limitations include insufficient high-quality studies and limited reporting on cannabis dosage and timing.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;FOD/difficulty should be recognized as a qualifying condition for medical cannabis use. Given the existing evidence supporting its potential efficacy, medical cannabis warrants consideration as a first-line treatment. More randomized controlled trials are needed to clarify optimal dosing, routes of administration, strain specificity, ti","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 4","pages":"qfaf061"},"PeriodicalIF":2.0,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12343064/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144848987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Difficulties in emotion regulation, repetitive negative thinking, and sexual and psychological distress: a two-wave longitudinal mediation study using a transdiagnostic approach. 情绪调节困难、重复消极思维、性和心理困扰:一项采用跨诊断方法的双波纵向中介研究。
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-11 eCollection Date: 2025-08-01 DOI: 10.1093/sexmed/qfaf052
Catarina F Raposo, Pedro J Nobre, Pedro J Rosa, Patrícia M Pascoal

Background: Sexual distress is a critical element in diagnosing sexual dysfunction. Recent research using a cross-sectional design has supported the adequacy of a transdiagnostic approach for its understanding.

Aim: This exploratory study aimed to investigate the mediating role of repetitive negative thinking between difficulties in emotional regulation and sexual and psychological distress in a community sample.

Methods: We used a quantitative longitudinal design with measures including a sociodemographic questionnaire, the Difficulties in Emotion Regulation Scale-Short Form, the Persistent and Intrusive Negative Thoughts Scale, the Sexual Distress Scale-Revised, and the Kessler Psychological Distress Scale.

Outcomes: Data were collected from 64 partnered individuals (85.9% women; age: M = 31.20, SD = 6.46).

Results: Correlational analysis across time revealed significant associations among difficulties in emotion regulation (T1 r = 0.37, T2 r = 0.32), repetitive negative thinking (T1 r = 0.30, T2 r = 0.27), psychological distress (T1 r = 0.37, T2 r = 0.55), and sexual distress (all at P < .01)​. The total effect of difficulties in emotion regulation on sexual distress was found to be positive (β = 0.20, P = .008) after controlling for frequency of sexual activity (r = -0.25, P < .05). Longitudinal mediation analysis indicated a significant negative indirect effect from difficulties in emotion regulation on sexual distress via repetitive negative thinking (β = -0.04, 95% CI [-0.008, -0.001]), suggesting a buffering effect over time on sexual distress.

Clinical implications: These results highlight the significance of recognizing difficulties in emotion regulation and repetitive negative thinking as coping strategies when examining sexual distress, emphasizing the need to explore the putative efficacy of therapeutic interventions focused on addressing these cognitive processes to decrease adverse sexual-related outcomes.

Strengths and limitations: These findings highlight the importance of acknowledging difficulties in emotion regulation and repetitive negative thinking as coping strategies in the study of sexual distress. However, the small sample size and the predominance of women participants limit generalizability. Further research with clinical samples and more diverse populations is needed to better understand the relevance of these aspects in assessment and therapy.

Conclusions: The findings imply that repetitive negative thinking may have potentially adaptive effects, indicating a nuanced role in coping strategies within the context of the study.

背景:性困扰是诊断性功能障碍的关键因素。最近使用横断面设计的研究支持跨诊断方法对其理解的充分性。目的:探讨重复性消极思维在社区情绪调节困难与性心理困扰之间的中介作用。方法:采用纵向定量设计,包括社会人口学问卷、情绪调节困难简易量表、持续性和侵入性消极思想量表、性困扰量表(修订版)和Kessler心理困扰量表。结果:收集了64名伴侣的数据(85.9%为女性;年龄:M = 31.20, SD = 6.46)。结果:在控制性活动频率(r = -0.25, P)后,情绪调节困难(T1 r = 0.37, T2 r = 0.32)、重复性消极思维(T1 r = 0.30, T2 r = 0.27)、心理困扰(T1 r = 0.37, T2 r = 0.55)和性困扰(P均为P = 0.008)具有显著相关性。这些结果强调了在检查性困扰时认识到情绪调节困难和重复消极思维作为应对策略的重要性,强调了探索治疗干预措施的假定功效的必要性,这些干预措施侧重于解决这些认知过程,以减少不良的性相关结果。优势和局限性:这些发现强调了承认情绪调节困难和重复消极思维作为应对策略在性困扰研究中的重要性。然而,小样本量和女性参与者的优势限制了普遍性。需要对临床样本和更多样化的人群进行进一步研究,以更好地了解这些方面在评估和治疗中的相关性。结论:研究结果表明,重复的消极思维可能具有潜在的适应性效应,表明在研究背景下应对策略的微妙作用。
{"title":"Difficulties in emotion regulation, repetitive negative thinking, and sexual and psychological distress: a two-wave longitudinal mediation study using a transdiagnostic approach.","authors":"Catarina F Raposo, Pedro J Nobre, Pedro J Rosa, Patrícia M Pascoal","doi":"10.1093/sexmed/qfaf052","DOIUrl":"10.1093/sexmed/qfaf052","url":null,"abstract":"<p><strong>Background: </strong>Sexual distress is a critical element in diagnosing sexual dysfunction. Recent research using a cross-sectional design has supported the adequacy of a transdiagnostic approach for its understanding.</p><p><strong>Aim: </strong>This exploratory study aimed to investigate the mediating role of repetitive negative thinking between difficulties in emotional regulation and sexual and psychological distress in a community sample.</p><p><strong>Methods: </strong>We used a quantitative longitudinal design with measures including a sociodemographic questionnaire, the Difficulties in Emotion Regulation Scale-Short Form, the Persistent and Intrusive Negative Thoughts Scale, the Sexual Distress Scale-Revised, and the Kessler Psychological Distress Scale.</p><p><strong>Outcomes: </strong>Data were collected from 64 partnered individuals (85.9% women; age: M = 31.20, SD = 6.46).</p><p><strong>Results: </strong>Correlational analysis across time revealed significant associations among difficulties in emotion regulation (T1 <i>r</i> = 0.37, T2 <i>r</i> = 0.32), repetitive negative thinking (T1 <i>r</i> = 0.30, T2 <i>r</i> = 0.27), psychological distress (T1 <i>r</i> = 0.37, T2 <i>r</i> = 0.55), and sexual distress (all at <i>P</i> < .01)​. The total effect of difficulties in emotion regulation on sexual distress was found to be positive (β = 0.20, <i>P</i> = .008) after controlling for frequency of sexual activity (<i>r</i> = -0.25, <i>P</i> < .05). Longitudinal mediation analysis indicated a significant negative indirect effect from difficulties in emotion regulation on sexual distress via repetitive negative thinking (β = -0.04, 95% CI [-0.008, -0.001]), suggesting a buffering effect over time on sexual distress.</p><p><strong>Clinical implications: </strong>These results highlight the significance of recognizing difficulties in emotion regulation and repetitive negative thinking as coping strategies when examining sexual distress, emphasizing the need to explore the putative efficacy of therapeutic interventions focused on addressing these cognitive processes to decrease adverse sexual-related outcomes.</p><p><strong>Strengths and limitations: </strong>These findings highlight the importance of acknowledging difficulties in emotion regulation and repetitive negative thinking as coping strategies in the study of sexual distress. However, the small sample size and the predominance of women participants limit generalizability. Further research with clinical samples and more diverse populations is needed to better understand the relevance of these aspects in assessment and therapy.</p><p><strong>Conclusions: </strong>The findings imply that repetitive negative thinking may have potentially adaptive effects, indicating a nuanced role in coping strategies within the context of the study.</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 4","pages":"qfaf052"},"PeriodicalIF":2.0,"publicationDate":"2025-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342931/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144849002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pelvic floor physical therapy in the treatment of a patient with persistent genital arousal disorder/genito-pelvic dysesthesia: a case report. 盆底物理疗法治疗持续性生殖器觉醒障碍/生殖器-盆腔感觉障碍1例
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-11 eCollection Date: 2025-08-01 DOI: 10.1093/sexmed/qfaf057
Tangdi Lin, Wenjia Lou, Guorong Fan, Lina Niu, Lan Zhu

Introduction: Persistent genital arousal disorder/genito-pelvic dysesthesia (PGAD/GPD) is a condition of persistent or recurrent, unwanted or intrusive sensation of genital arousal that is usually associated with a distressing feeling and has a great impact on patients' daily life. Pelvic floor physical therapy is one of the effective conservative treatment options that deserves increased attention.

Aims: This case report aims to provide a comprehensive pelvic floor physical therapy evaluation and treatment plans for a patient with PGAD/GPD that resulted in a complete resolution of symptoms.

Methods: The patient is a 63-year-old female who suffered from persistent and uncontrolled sexual arousal over 3 months. Despite her efforts, the symptoms gradually worsened and never completely resolved, resulting in significant distress and despair. Her examination findings include myofascial restrictions on superficial pelvic floor structures, hypertonic pelvic floor muscles with trigger points, radiating pain along with genitofemoral nerve innervated areas, and lack of pelvic floor muscle strength and coordination. Physical therapy treatment plan included patient education, manual therapy, muscle strengthening exercises, and home exercise programs.

Results: The patient's symptoms were completely resolved after a total of four pelvic floor physical therapy sessions. Home exercise program was able to maintain satisfactory treatment outcomes 3 months post treatment. No complaints were reported at the 6-month and 1-year follow-ups.

Conclusion: Genitofemoral nerve pathology may be a potential etiology for PGAD/GPD. Pelvic floor physical therapy can an effective medical treatment for PGAD/GPD originating from the pelvic and perineum region. A comprehensive pelvic floor examination and an evidence-based treatment plan will be able to improve symptoms and potentially resolve them completely.

简介:持续性生殖器觉醒障碍/生殖盆腔感觉障碍(PGAD/GPD)是一种持续或反复出现的、不想要的或侵入性的生殖器觉醒感觉,通常伴有痛苦的感觉,对患者的日常生活有很大的影响。盆底物理治疗是一种有效的保守治疗方法,值得重视。目的:本病例报告旨在为一名pad /GPD患者提供全面的盆底物理治疗评估和治疗方案,使其症状得到完全解决。方法:患者女性,63岁,持续不可控性唤起3个多月。尽管她的努力,症状逐渐恶化,从未完全解决,导致严重的痛苦和绝望。检查结果包括盆底浅表结构肌筋膜受限,伴有触发点的盆底肌肉高渗,生殖股神经支配区放射性疼痛,盆底肌肉力量和协调性缺乏。物理治疗方案包括患者教育、手工治疗、肌肉强化练习和家庭锻炼项目。结果:患者经四次盆底物理治疗后症状完全缓解。家庭锻炼方案能够在治疗后3个月保持满意的治疗效果。随访6个月和1年,无患者投诉。结论:生殖股神经病变可能是pad /GPD的潜在病因。盆底物理治疗可以有效治疗起源于盆腔和会阴区域的pad /GPD。全面的盆底检查和循证治疗计划将能够改善症状并有可能完全解决它们。
{"title":"Pelvic floor physical therapy in the treatment of a patient with persistent genital arousal disorder/genito-pelvic dysesthesia: a case report.","authors":"Tangdi Lin, Wenjia Lou, Guorong Fan, Lina Niu, Lan Zhu","doi":"10.1093/sexmed/qfaf057","DOIUrl":"10.1093/sexmed/qfaf057","url":null,"abstract":"<p><strong>Introduction: </strong>Persistent genital arousal disorder/genito-pelvic dysesthesia (PGAD/GPD) is a condition of persistent or recurrent, unwanted or intrusive sensation of genital arousal that is usually associated with a distressing feeling and has a great impact on patients' daily life. Pelvic floor physical therapy is one of the effective conservative treatment options that deserves increased attention.</p><p><strong>Aims: </strong>This case report aims to provide a comprehensive pelvic floor physical therapy evaluation and treatment plans for a patient with PGAD/GPD that resulted in a complete resolution of symptoms.</p><p><strong>Methods: </strong>The patient is a 63-year-old female who suffered from persistent and uncontrolled sexual arousal over 3 months. Despite her efforts, the symptoms gradually worsened and never completely resolved, resulting in significant distress and despair. Her examination findings include myofascial restrictions on superficial pelvic floor structures, hypertonic pelvic floor muscles with trigger points, radiating pain along with genitofemoral nerve innervated areas, and lack of pelvic floor muscle strength and coordination. Physical therapy treatment plan included patient education, manual therapy, muscle strengthening exercises, and home exercise programs.</p><p><strong>Results: </strong>The patient's symptoms were completely resolved after a total of four pelvic floor physical therapy sessions. Home exercise program was able to maintain satisfactory treatment outcomes 3 months post treatment. No complaints were reported at the 6-month and 1-year follow-ups.</p><p><strong>Conclusion: </strong>Genitofemoral nerve pathology may be a potential etiology for PGAD/GPD. Pelvic floor physical therapy can an effective medical treatment for PGAD/GPD originating from the pelvic and perineum region. A comprehensive pelvic floor examination and an evidence-based treatment plan will be able to improve symptoms and potentially resolve them completely.</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 4","pages":"qfaf057"},"PeriodicalIF":2.0,"publicationDate":"2025-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342909/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144849004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hinokiflavone alleviates high-fat diet-induced erectile dysfunction via the EGFR/PI3K/Akt/eNOS signaling pathway. Hinokiflavone通过EGFR/PI3K/Akt/eNOS信号通路缓解高脂肪饮食诱导的勃起功能障碍。
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-06 eCollection Date: 2025-08-01 DOI: 10.1093/sexmed/qfaf059
Peng-Chao Gao, Xiao-Hui Tan, Man-Cheng Xia, Ke-Fan Li, Fang-Zhou Zhao, Hong-Gang Ying, Zhuo Zhou, Yi-Ming Yuan, Tie-Gui Nan, Rui-Li Guan

Background: Erectile dysfunction (ED) is a significant health issue affecting the global male population, with a complex and multifaceted etiology. High-fat diet (HFD) is known to impair endothelial function and promote the development of ED. Hinokiflavone (HINO), a naturally occurring biflavonoid, has garnered attention for its notable antioxidant and anti-inflammatory activities, suggesting its potential therapeutic role in treating ED.

Aim: This study aims to investigate the therapeutic effects and underlying mechanisms of HINO in HFD-induced ED.

Methods: Network pharmacology and molecular dynamics simulation were employed to predict relevant targets and analyze their binding kinetics. Rat corpus cavernosum endothelial cells (RCCECs) were treated with palmitic acid in vitro to induce metabolic dysfunction. The ED model was established in vivo by feeding male rats an HFD (60 kcal% fat).

Outcomes: The primary outcomes were the target genes and pathways associated with HINO and the evaluation of its therapeutic potential in HFD-induced ED.

Results: Bioinformatics analyses identified the epidermal growth factor receptor (EGFR) and protein kinase B (Akt) as key molecular targets of HINO. Treatment with HINO promoted RCCEC proliferation, enhanced antioxidant activities, and increased nitric oxide production. The administration of HINO ameliorated erectile dysfunction, improved serum lipid profiles, and reduced oxidative stress in HFD-fed rats. The protective effects of HINO against endothelial dysfunction and impaired cell viability were mediated through modulation of the EGFR/PI3K/Akt/eNOS signaling pathway.

Clinical translation: The results provide a strong rationale for further investigation of HINO as a novel therapeutic agent for ED, with promising implications for future clinical applications.

Strengths and limitations: In this study, we found that HINO could mitigate HFD-induced ED. Limitations of the study include that the alternative mechanisms of HINO were not fully explored in these settings.

Conclusions: Our findings underscore the pharmacological properties of HINO in the management of ED, particularly through the modulation of critical targets such as EGFR.

背景:勃起功能障碍(ED)是影响全球男性人口的一个重要健康问题,具有复杂和多方面的病因。高脂肪饮食(HFD)会损害内皮功能,促进ED的发生。Hinokiflavone (HINO)是一种天然存在的双类黄酮,因其显著的抗氧化和抗炎活性而受到关注,提示其在ED的治疗中具有潜在的治疗作用。目的:本研究旨在探讨HINO对HFD诱导ED的治疗作用及其机制。采用网络药理学和分子动力学模拟方法预测相关靶点并分析其结合动力学。用棕榈酸处理大鼠海绵体内皮细胞(RCCECs),诱导其体外代谢功能障碍。通过给雄性大鼠喂食HFD (60 kcal%脂肪)建立ED模型。结果:主要结果是与HINO相关的靶基因和通路,以及对其治疗hfd诱导ed的潜力的评估。结果:生物信息学分析确定了表皮生长因子受体(EGFR)和蛋白激酶B (Akt)是HINO的关键分子靶点。HINO处理促进RCCEC增殖,增强抗氧化活性,增加一氧化氮的产生。在饲喂hfd的大鼠中,HINO改善了勃起功能障碍,改善了血清脂质谱,并降低了氧化应激。HINO对内皮功能障碍和细胞活力受损的保护作用是通过调节EGFR/PI3K/Akt/eNOS信号通路介导的。临床翻译:该结果为进一步研究HINO作为ED的新型治疗剂提供了强有力的理论依据,对未来的临床应用具有重要意义。优势和局限性:在本研究中,我们发现HINO可以减轻hfd诱导的ED。该研究的局限性包括HINO的替代机制没有在这些环境中得到充分的探索。结论:我们的研究结果强调了HINO在ED治疗中的药理学特性,特别是通过调节关键靶点如EGFR。
{"title":"Hinokiflavone alleviates high-fat diet-induced erectile dysfunction via the EGFR/PI3K/Akt/eNOS signaling pathway.","authors":"Peng-Chao Gao, Xiao-Hui Tan, Man-Cheng Xia, Ke-Fan Li, Fang-Zhou Zhao, Hong-Gang Ying, Zhuo Zhou, Yi-Ming Yuan, Tie-Gui Nan, Rui-Li Guan","doi":"10.1093/sexmed/qfaf059","DOIUrl":"10.1093/sexmed/qfaf059","url":null,"abstract":"<p><strong>Background: </strong>Erectile dysfunction (ED) is a significant health issue affecting the global male population, with a complex and multifaceted etiology. High-fat diet (HFD) is known to impair endothelial function and promote the development of ED. Hinokiflavone (HINO), a naturally occurring biflavonoid, has garnered attention for its notable antioxidant and anti-inflammatory activities, suggesting its potential therapeutic role in treating ED.</p><p><strong>Aim: </strong>This study aims to investigate the therapeutic effects and underlying mechanisms of HINO in HFD-induced ED.</p><p><strong>Methods: </strong>Network pharmacology and molecular dynamics simulation were employed to predict relevant targets and analyze their binding kinetics. Rat corpus cavernosum endothelial cells (RCCECs) were treated with palmitic acid <i>in vitro</i> to induce metabolic dysfunction. The ED model was established <i>in vivo</i> by feeding male rats an HFD (60 kcal% fat).</p><p><strong>Outcomes: </strong>The primary outcomes were the target genes and pathways associated with HINO and the evaluation of its therapeutic potential in HFD-induced ED.</p><p><strong>Results: </strong>Bioinformatics analyses identified the epidermal growth factor receptor (EGFR) and protein kinase B (Akt) as key molecular targets of HINO. Treatment with HINO promoted RCCEC proliferation, enhanced antioxidant activities, and increased nitric oxide production. The administration of HINO ameliorated erectile dysfunction, improved serum lipid profiles, and reduced oxidative stress in HFD-fed rats. The protective effects of HINO against endothelial dysfunction and impaired cell viability were mediated through modulation of the EGFR/PI3K/Akt/eNOS signaling pathway.</p><p><strong>Clinical translation: </strong>The results provide a strong rationale for further investigation of HINO as a novel therapeutic agent for ED, with promising implications for future clinical applications.</p><p><strong>Strengths and limitations: </strong>In this study, we found that HINO could mitigate HFD-induced ED. Limitations of the study include that the alternative mechanisms of HINO were not fully explored in these settings.</p><p><strong>Conclusions: </strong>Our findings underscore the pharmacological properties of HINO in the management of ED, particularly through the modulation of critical targets such as EGFR.</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 4","pages":"qfaf059"},"PeriodicalIF":2.0,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12341904/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144849003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are obstetrics and gynecology residents sexually satisfied? 妇产科住院医师对性生活满意吗?
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-05 eCollection Date: 2025-08-01 DOI: 10.1093/sexmed/qfaf026
Natasha Kamat, Sheryl Kingsberg, Erika Kelley

Background: There is a dearth of data on the impact of residency on resident sexual health. What exists utilizes the Female Sexual Function Index (FSFI) and the International Index of Erectile Function (IIEF), which primarily assess function and often refer to sexual activity as penetrative sexual intercourse. This presents a limited view on sexual activity and sexuality.

Aim: The objective of this study was to evaluate the effect of obstetrics and gynecology (OBGYN) residency on resident sexual satisfaction using the gender and relationship neutral New Sexual Satisfaction Scale (NSSS).

Methods: Between July 2022 and August 2023, 137 current US OBGYN residents were recruited and completed questionnaires at three timepoints (baseline, 6 months, and 12 months) assessing their demographic data, city and level of training, work hours, gender identity, sexual orientation, relationship status, and the NSSS.

Outcomes: We hypothesized that OBGYN residents in later years of residency would report lower sexual satisfaction than post graduate year one residents (PGY-1 s) and that sexual satisfaction would decrease later in OBGYN residency due to the cumulative effect of work stress.

Results: There was a significant increase in NSSS total scores from baseline (M = 67.5) to 12 month follow-up (M = 72.1) in all residents. However, when the sample was stratified by year of residency, postgraduate year one residents (PGY-1 s) had a decrease in their NSSS total and subscale scores over time as compared to postgraduate year two residents and above who had an overall increase in their NSSS total and subscale scores over time.

Clinical implications: This data presents evidence to support initiatives by OBGYN residency programs to support sexual health and resilience training and opens avenues for further research into sexual satisfaction in other medical subspecialities.

Strengths & limitations: Strengths include utilizing a validated, gender neutral survey. Limitations include small sample size and opt-in study design.

Conclusion: The increase in sexual satisfaction in later years of OBGYN residency may be due to increased resilience over the course of residency. However, the unique stress of the transition from medical school to residency may be highlighted in the decrease in sexual satisfaction scores over time demonstrated in the PGY-1 s.

背景:居住对居民性健康影响的数据缺乏。现有的方法是使用女性性功能指数(FSFI)和国际勃起功能指数(IIEF),它们主要评估性功能,通常将性活动称为插入性行为。这是对性活动和性行为的一种有限的看法。目的:本研究采用性别与关系中性的新型性满意度量表(NSSS),探讨妇产科住院医师对住院医师性满意度的影响。方法:在2022年7月至2023年8月期间,招募了137名美国OBGYN现有居民,并在三个时间点(基线,6个月和12个月)完成问卷调查,评估他们的人口统计数据,城市和培训水平,工作时间,性别认同,性取向,关系状况和NSSS。结果:我们假设在后期实习的妇产科住院医师的性满意度低于研究生一年级实习医师(PGY-1 s),并且由于工作压力的累积效应,在后期实习的妇产科住院医师的性满意度会下降。结果:从基线(M = 67.5)到12个月随访(M = 72.1),所有住院患者的NSSS总分显著增加。然而,当样本按居住年份分层时,与研究生二年及以上的住院医师相比,研究生一年级住院医师(PGY-1 s)的NSSS总分数和子量表分数随时间的推移而下降,而研究生二年级及以上的住院医师的NSSS总分数和子量表分数随时间的推移而总体上升。临床意义:该数据为妇产科住院医师项目提供了支持性健康和恢复力培训的证据,并为进一步研究其他医学专科的性满意度开辟了道路。优势和局限性:优势包括使用有效的、性别中立的调查。局限性包括样本量小和选择性研究设计。结论:在妇产科住院治疗的后期,性满意度的提高可能是由于住院治疗过程中心理弹性的增强。然而,PGY-1所显示的性满意度分数随着时间的推移而下降,可能突出了从医学院过渡到住院医师的独特压力。
{"title":"Are obstetrics and gynecology residents sexually satisfied?","authors":"Natasha Kamat, Sheryl Kingsberg, Erika Kelley","doi":"10.1093/sexmed/qfaf026","DOIUrl":"10.1093/sexmed/qfaf026","url":null,"abstract":"<p><strong>Background: </strong>There is a dearth of data on the impact of residency on resident sexual health. What exists utilizes the Female Sexual Function Index (FSFI) and the International Index of Erectile Function (IIEF), which primarily assess function and often refer to sexual activity as penetrative sexual intercourse. This presents a limited view on sexual activity and sexuality.</p><p><strong>Aim: </strong>The objective of this study was to evaluate the effect of obstetrics and gynecology (OBGYN) residency on resident sexual satisfaction using the gender and relationship neutral New Sexual Satisfaction Scale (NSSS).</p><p><strong>Methods: </strong>Between July 2022 and August 2023, 137 current US OBGYN residents were recruited and completed questionnaires at three timepoints (baseline, 6 months, and 12 months) assessing their demographic data, city and level of training, work hours, gender identity, sexual orientation, relationship status, and the NSSS.</p><p><strong>Outcomes: </strong>We hypothesized that OBGYN residents in later years of residency would report lower sexual satisfaction than post graduate year one residents (PGY-1 s) and that sexual satisfaction would decrease later in OBGYN residency due to the cumulative effect of work stress.</p><p><strong>Results: </strong>There was a significant increase in NSSS total scores from baseline (<i>M</i> = 67.5) to 12 month follow-up (<i>M</i> = 72.1) in all residents. However, when the sample was stratified by year of residency, postgraduate year one residents (PGY-1 s) had a decrease in their NSSS total and subscale scores over time as compared to postgraduate year two residents and above who had an overall increase in their NSSS total and subscale scores over time.</p><p><strong>Clinical implications: </strong>This data presents evidence to support initiatives by OBGYN residency programs to support sexual health and resilience training and opens avenues for further research into sexual satisfaction in other medical subspecialities.</p><p><strong>Strengths & limitations: </strong>Strengths include utilizing a validated, gender neutral survey. Limitations include small sample size and opt-in study design.</p><p><strong>Conclusion: </strong>The increase in sexual satisfaction in later years of OBGYN residency may be due to increased resilience over the course of residency. However, the unique stress of the transition from medical school to residency may be highlighted in the decrease in sexual satisfaction scores over time demonstrated in the PGY-1 s.</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 4","pages":"qfaf026"},"PeriodicalIF":2.0,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12358247/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144883589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identifying therapeutic targets for erectile dysfunction in the European population using genome-wide Mendelian randomization. 使用全基因组孟德尔随机化确定欧洲人群勃起功能障碍的治疗靶点。
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-05 eCollection Date: 2025-08-01 DOI: 10.1093/sexmed/qfaf056
Peng Guo, Hongjian Zhang, Rong Cao, Huan Guo, Xu Zhou, Heng Pan, Junwei Lin, Qiusong Liu, Zheng Wan

Background: Erectile dysfunction (ED) is a prevalent condition with current treatments limited by suboptimal efficacy and adverse effects. Mendelian randomization (MR) offers a promising approach to identify potential genetic targets for novel therapies.

Aim: We performed a genome-wide MR study on druggable genes to find ED therapies.

Methods: We collected data on drug-targetable genes and their impact on blood expression quantitative trait loci (eQTLs). Using two-sample MR with genome-wide association studies data, we pinpointed genes linked to ED and conducted enrichment analysis. We also built protein networks and predicted drugs to support treatment development.

Outcomes: This comprehensive strategy provides a robust framework for the advancement of more efficacious and precisely targeted treatments for ED.

Results: The MR analysis identified 124 genes significantly associated with ED. Enrichment analysis revealed these genes are involved in signal transduction, protein phosphorylation, plasma membrane, cytoplasm, ATP binding, and the PI3K-Akt signaling pathway. We identified the top 10 hub genes: PRKCA, IFNG, ITGB1, PPARG, PTK2, LAMA5, BCL2L1, CD3D, CD3E, and CD27. Our study highlighted three potential drugs targeting three of these hub genes: benztropine for CD27, teplizumab for CD3E, and natalizumab for ITGB1.

Clinical translation: The study identifies high-priority targets for ED therapy, including approved drugs amenable to rapid repurposing trials.

Strengths and limitations: Multi-omics integration enhanced causal validity; drug predictions leveraged existing therapeutic knowledge. Tissue-specific expression quantitative trait loci confounders and lack of experimental validation for prioritized drugs require caution.

Conclusion: This work advances ED research by mapping druggable genes (PRKCA, IFNG, ITGB1) and pathways via MR, offering precision medicine opportunities and actionable drug repurposing candidates.

背景:勃起功能障碍(ED)是一种普遍的疾病,目前的治疗方法受到效果欠佳和不良反应的限制。孟德尔随机化(MR)提供了一种很有前途的方法来识别潜在的基因靶点,用于新疗法。目的:我们对可用药基因进行全基因组磁共振研究,以寻找ED的治疗方法。方法:收集药物靶向基因及其对血液表达数量性状位点(qtl)的影响。利用两样本MR和全基因组关联研究数据,我们确定了与ED相关的基因,并进行了富集分析。我们还建立了蛋白质网络并预测了支持治疗发展的药物。结果:磁共振分析鉴定出124个与ED显著相关的基因。富集分析显示,这些基因参与信号转导、蛋白磷酸化、质膜、细胞质、ATP结合和PI3K-Akt信号通路。我们确定了前10个枢纽基因:PRKCA、IFNG、ITGB1、PPARG、PTK2、LAMA5、BCL2L1、CD3D、CD3E和CD27。我们的研究强调了针对这三个中心基因的三种潜在药物:用于CD27的苯托品,用于CD3E的替普利单抗和用于ITGB1的那他珠单抗。临床翻译:该研究确定了ED治疗的高优先级靶点,包括可用于快速再利用试验的已批准药物。优势与局限:多组学整合增强了因果效度;药物预测利用了现有的治疗知识。组织特异性表达、定量性状位点混杂和缺乏实验验证的优先药物需要谨慎。结论:本研究通过MR定位可用药基因(PRKCA、IFNG、ITGB1)和通路,为ED研究提供精准医疗机会和可操作的药物改造候选药物。
{"title":"Identifying therapeutic targets for erectile dysfunction in the European population using genome-wide Mendelian randomization.","authors":"Peng Guo, Hongjian Zhang, Rong Cao, Huan Guo, Xu Zhou, Heng Pan, Junwei Lin, Qiusong Liu, Zheng Wan","doi":"10.1093/sexmed/qfaf056","DOIUrl":"10.1093/sexmed/qfaf056","url":null,"abstract":"<p><strong>Background: </strong>Erectile dysfunction (ED) is a prevalent condition with current treatments limited by suboptimal efficacy and adverse effects. Mendelian randomization (MR) offers a promising approach to identify potential genetic targets for novel therapies.</p><p><strong>Aim: </strong>We performed a genome-wide MR study on druggable genes to find ED therapies.</p><p><strong>Methods: </strong>We collected data on drug-targetable genes and their impact on blood expression quantitative trait loci (eQTLs). Using two-sample MR with genome-wide association studies data, we pinpointed genes linked to ED and conducted enrichment analysis. We also built protein networks and predicted drugs to support treatment development.</p><p><strong>Outcomes: </strong>This comprehensive strategy provides a robust framework for the advancement of more efficacious and precisely targeted treatments for ED.</p><p><strong>Results: </strong>The MR analysis identified 124 genes significantly associated with ED. Enrichment analysis revealed these genes are involved in signal transduction, protein phosphorylation, plasma membrane, cytoplasm, ATP binding, and the PI3K-Akt signaling pathway. We identified the top 10 hub genes: PRKCA, IFNG, ITGB1, PPARG, PTK2, LAMA5, BCL2L1, CD3D, CD3E, and CD27. Our study highlighted three potential drugs targeting three of these hub genes: benztropine for CD27, teplizumab for CD3E, and natalizumab for ITGB1.</p><p><strong>Clinical translation: </strong>The study identifies high-priority targets for ED therapy, including approved drugs amenable to rapid repurposing trials.</p><p><strong>Strengths and limitations: </strong>Multi-omics integration enhanced causal validity; drug predictions leveraged existing therapeutic knowledge. Tissue-specific expression quantitative trait loci confounders and lack of experimental validation for prioritized drugs require caution.</p><p><strong>Conclusion: </strong>This work advances ED research by mapping druggable genes (PRKCA, IFNG, ITGB1) and pathways via MR, offering precision medicine opportunities and actionable drug repurposing candidates.</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 4","pages":"qfaf056"},"PeriodicalIF":2.0,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12358251/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144883590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Translation, cultural adaptation, and psychometric validation of the Female Sexual Function Index to Lebanese Arabic (FSFI-LB). 黎巴嫩阿拉伯语女性性功能指数(FSFI-LB)的翻译、文化适应和心理测量验证。
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-05 eCollection Date: 2025-08-01 DOI: 10.1093/sexmed/qfaf055
Stephanie Zakhour, Walter Gonçalves, Hugo Santos, Douglas Rodrigues, Nadine El Kassis, David Atallah, Antonio Egídio Nardi, Aline Sardinha

Background: The Female Sexual Function Index (FSFI) is widely used to assess female sexual function, but its applicability in Lebanon is limited due to linguistic and cultural barriers.

Aim: This study aimed to develop and validate a Lebanese Arabic version of the FSFI (FSFI-LB) to improve accessibility for clinical and research use.

Methods: A study was conducted with 119 Lebanese women between April 2023 and June 2024 at Hôtel-Dieu de France Hospital, Beirut. The FSFI was translated, back-translated, and psychometrically validated using exploratory factor analysis, Cronbach's alpha, test-retest reliability, and factor correlations.

Outcomes: The FSFI-LB showed excellent internal consistency (Cronbach's alpha = 0.973) and test-retest reliability (r = 0.9997), with a Kaiser-Meyer-Olkin value of 0.925 and significant Bartlett's test of sphericity (P < .001). Test-retest reliability was assessed in a subsample of 42 participants after 4 weeks and demonstrated high consistency across all domains (r > 0.99) and total scale reliability (r = 0.9997).

Results: A six-factor model was retained for the FSFI-LB, aligning with the original FSFI, with the pain domain showing the weakest correlations with other domains. The questionnaire included English translations alongside Arabic terms for improved comprehension.

Clinical translation: The FSFI-LB is a reliable tool for assessing female sexual function in Lebanon, ensuring cultural and linguistic sensitivity for diverse populations.

Strengths and limitations: The study's strengths include robust psychometric validation and the adaptation of a widely used instrument. The limitations include the focus on a specific Lebanese population, which may limit generalizability to other Arabic-speaking communities.

Conclusion: The FSFI-LB is a valid and reliable tool for assessing female sexual function, contributing to the development of culturally appropriate measures in sexual health research and clinical practice.

背景:女性性功能指数(FSFI)被广泛用于评估女性性功能,但由于语言和文化障碍,其在黎巴嫩的适用性受到限制。目的:本研究旨在开发和验证黎巴嫩阿拉伯语版本的FSFI (FSFI- lb),以提高临床和研究使用的可及性。方法:2023年4月至2024年6月在贝鲁特Hôtel-Dieu de France医院对119名黎巴嫩妇女进行了一项研究。对FSFI进行翻译、反翻译,并使用探索性因子分析、Cronbach’s alpha、重测信度和因子相关性对其进行心理测量学验证。结果:FSFI-LB具有良好的内部一致性(Cronbach's alpha = 0.973)和重测信度(r = 0.9997), Kaiser-Meyer-Olkin值为0.925,Bartlett's球形检验(P = 0.99)和总量表信度(r = 0.9997)显著。结果:FSFI- lb保留了一个六因素模型,与原始FSFI一致,疼痛域与其他域的相关性最弱。问卷包括英语翻译和阿拉伯语术语,以提高理解能力。临床翻译:FSFI-LB是评估黎巴嫩女性性功能的可靠工具,确保不同人群的文化和语言敏感性。优势和局限性:该研究的优势包括强大的心理测量验证和广泛使用的工具的适应性。这些限制包括集中于特定的黎巴嫩人口,这可能限制推广到其他讲阿拉伯语的社区。结论:FSFI-LB是一种有效、可靠的评估女性性功能的工具,有助于在性健康研究和临床实践中制定适合文化的措施。
{"title":"Translation, cultural adaptation, and psychometric validation of the Female Sexual Function Index to Lebanese Arabic (FSFI-LB).","authors":"Stephanie Zakhour, Walter Gonçalves, Hugo Santos, Douglas Rodrigues, Nadine El Kassis, David Atallah, Antonio Egídio Nardi, Aline Sardinha","doi":"10.1093/sexmed/qfaf055","DOIUrl":"10.1093/sexmed/qfaf055","url":null,"abstract":"<p><strong>Background: </strong>The Female Sexual Function Index (FSFI) is widely used to assess female sexual function, but its applicability in Lebanon is limited due to linguistic and cultural barriers.</p><p><strong>Aim: </strong>This study aimed to develop and validate a Lebanese Arabic version of the FSFI (FSFI-LB) to improve accessibility for clinical and research use.</p><p><strong>Methods: </strong>A study was conducted with 119 Lebanese women between April 2023 and June 2024 at Hôtel-Dieu de France Hospital, Beirut. The FSFI was translated, back-translated, and psychometrically validated using exploratory factor analysis, Cronbach's alpha, test-retest reliability, and factor correlations.</p><p><strong>Outcomes: </strong>The FSFI-LB showed excellent internal consistency (Cronbach's alpha = 0.973) and test-retest reliability (<i>r</i> = 0.9997), with a Kaiser-Meyer-Olkin value of 0.925 and significant Bartlett's test of sphericity (<i>P</i> < .001). Test-retest reliability was assessed in a subsample of 42 participants after 4 weeks and demonstrated high consistency across all domains (<i>r</i> > 0.99) and total scale reliability (<i>r</i> = 0.9997).</p><p><strong>Results: </strong>A six-factor model was retained for the FSFI-LB, aligning with the original FSFI, with the pain domain showing the weakest correlations with other domains. The questionnaire included English translations alongside Arabic terms for improved comprehension.</p><p><strong>Clinical translation: </strong>The FSFI-LB is a reliable tool for assessing female sexual function in Lebanon, ensuring cultural and linguistic sensitivity for diverse populations.</p><p><strong>Strengths and limitations: </strong>The study's strengths include robust psychometric validation and the adaptation of a widely used instrument. The limitations include the focus on a specific Lebanese population, which may limit generalizability to other Arabic-speaking communities.</p><p><strong>Conclusion: </strong>The FSFI-LB is a valid and reliable tool for assessing female sexual function, contributing to the development of culturally appropriate measures in sexual health research and clinical practice.</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 4","pages":"qfaf055"},"PeriodicalIF":2.0,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12358250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144883591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of a single functional neurology session on thermography of the genital region and sexual function in patients with premature ejaculation. 早泄患者单次功能性神经学会话对生殖器区域热成像和性功能的影响。
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-07-27 eCollection Date: 2025-06-01 DOI: 10.1093/sexmed/qfaf046
Vicente Javier Clemente-Suárez, Jorge Rey-Mota, Guillermo Escribano-Colmena, Noelia Vanessa Marín, Jesús Fernandez-Lucas

Background: Premature ejaculation (PE) is a common male sexual dysfunction with limited long-term therapeutic options. Pharmacological and behavioral treatments often yield only temporary improvement, and alternative neuromodulatory strategies remain underexplored. Functional neurology, which targets autonomic and sensory-motor regulation, may offer a novel approach.

Aim: To evaluate the effect of a single functional neurology intervention on genital thermoregulation and ejaculatory latency in men with PE.

Methods: Fifty-two men diagnosed with PE participated in a pre-post intervention study. Each underwent a single session of functional neurology aimed at modulating nociceptor and mechanoreceptor pathways. Genital thermoregulation was assessed using infrared thermography, and ejaculatory function was measured via intravaginal ejaculatory latency time (IELT) and self-report at baseline, after the first post-treatment sexual encounter, and at 1-month follow-up. Statistical analyses included repeated-measures ANOVA, paired t-tests, Pearson correlation, and multiple regression.

Outcomes: Significant improvements in IELT and genital temperature were expected following the intervention, supporting its role in enhancing autonomic regulation and microvascular circulation.

Results: Intravaginal ejaculatory latency time increased significantly from a baseline of 20.4 ± 11.5 seconds to 439.2 ± 214.5 seconds post-treatment, with sustained effects at 1 month (498.0 ± 171.6 seconds; P < .001). Infrared thermography revealed significant increases in temperature in the glans, testicles, and abdomen (all P < .001), indicating enhanced peripheral circulation. Glans temperature change was the strongest predictor of testicular thermoregulation (β = 0.513, P < .001). Principal component analysis highlighted that glans and testicular areas contributed most to thermal variance post-treatment. A ≥1 °C increase in genital temperature was observed in 60% of participants.

Clinical implications: Functional neurology may be a non-invasive, fast-acting intervention for improving ejaculatory control in PE by promoting autonomic balance and vascular function. Thermography proved useful as a biomarker for physiological changes and treatment efficacy.

Strengths and limitations: This study is the first to evaluate thermographic and ejaculatory outcomes after a functional neurology intervention in PE. Strengths include objective and subjective measures, while limitations involve the lack of a control group, small sample size, and short-term follow-up. These results should be confirmed through randomized controlled trials.

Conclusion: A single session of functional neurology significantly improved both genital thermoregulation and ejaculatory latency in men with PE. These find

背景:早泄(PE)是一种常见的男性性功能障碍,长期治疗方案有限。药理学和行为治疗往往只能产生暂时的改善,替代的神经调节策略仍未得到充分探索。以自主神经和感觉运动调节为目标的功能神经学可能提供一种新的方法。目的:评价单一功能神经学干预对PE男性生殖器体温调节和射精潜伏期的影响。方法:52名确诊为PE的男性参与了干预前和干预后的研究。每个人都接受了一次旨在调节伤害感受器和机械感受器通路的功能神经学治疗。使用红外热像仪评估生殖器体温调节,通过阴道内射精潜伏期(IELT)和基线、治疗后第一次性接触后和1个月随访时的自我报告来测量射精功能。统计分析包括重复测量方差分析、配对t检验、Pearson相关和多元回归。结果:在干预后,雅思成绩和生殖器温度有望显著改善,支持其在增强自主调节和微血管循环中的作用。结果:治疗后阴道内射精潜伏期从基线的20.4±11.5秒显著增加到439.2±214.5秒,持续1个月(498.0±171.6秒;临床意义:功能神经学可能是通过促进自主神经平衡和血管功能来改善PE患者射精控制的一种非侵入性、速效干预。热成像被证明是一种有用的生理变化和治疗效果的生物标志物。优势和局限性:这项研究首次评估了PE患者在功能性神经病学干预后的热成像和射精结果。优势包括客观和主观测量,而限制包括缺乏对照组、小样本量和短期随访。这些结果需要通过随机对照试验来证实。结论:单次功能性神经学治疗可显著改善PE患者的生殖器体温调节和射精潜伏期。这些发现支持将神经调节技术整合到性功能障碍治疗的多学科策略中。
{"title":"The effect of a single functional neurology session on thermography of the genital region and sexual function in patients with premature ejaculation.","authors":"Vicente Javier Clemente-Suárez, Jorge Rey-Mota, Guillermo Escribano-Colmena, Noelia Vanessa Marín, Jesús Fernandez-Lucas","doi":"10.1093/sexmed/qfaf046","DOIUrl":"10.1093/sexmed/qfaf046","url":null,"abstract":"<p><strong>Background: </strong>Premature ejaculation (PE) is a common male sexual dysfunction with limited long-term therapeutic options. Pharmacological and behavioral treatments often yield only temporary improvement, and alternative neuromodulatory strategies remain underexplored. Functional neurology, which targets autonomic and sensory-motor regulation, may offer a novel approach.</p><p><strong>Aim: </strong>To evaluate the effect of a single functional neurology intervention on genital thermoregulation and ejaculatory latency in men with PE.</p><p><strong>Methods: </strong>Fifty-two men diagnosed with PE participated in a pre-post intervention study. Each underwent a single session of functional neurology aimed at modulating nociceptor and mechanoreceptor pathways. Genital thermoregulation was assessed using infrared thermography, and ejaculatory function was measured via intravaginal ejaculatory latency time (IELT) and self-report at baseline, after the first post-treatment sexual encounter, and at 1-month follow-up. Statistical analyses included repeated-measures ANOVA, paired <i>t</i>-tests, Pearson correlation, and multiple regression.</p><p><strong>Outcomes: </strong>Significant improvements in IELT and genital temperature were expected following the intervention, supporting its role in enhancing autonomic regulation and microvascular circulation.</p><p><strong>Results: </strong>Intravaginal ejaculatory latency time increased significantly from a baseline of 20.4 ± 11.5 seconds to 439.2 ± 214.5 seconds post-treatment, with sustained effects at 1 month (498.0 ± 171.6 seconds; <i>P</i> < .001). Infrared thermography revealed significant increases in temperature in the glans, testicles, and abdomen (all <i>P</i> < .001), indicating enhanced peripheral circulation. Glans temperature change was the strongest predictor of testicular thermoregulation (β = 0.513, <i>P</i> < .001). Principal component analysis highlighted that glans and testicular areas contributed most to thermal variance post-treatment. A ≥1 °C increase in genital temperature was observed in 60% of participants.</p><p><strong>Clinical implications: </strong>Functional neurology may be a non-invasive, fast-acting intervention for improving ejaculatory control in PE by promoting autonomic balance and vascular function. Thermography proved useful as a biomarker for physiological changes and treatment efficacy.</p><p><strong>Strengths and limitations: </strong>This study is the first to evaluate thermographic and ejaculatory outcomes after a functional neurology intervention in PE. Strengths include objective and subjective measures, while limitations involve the lack of a control group, small sample size, and short-term follow-up. These results should be confirmed through randomized controlled trials.</p><p><strong>Conclusion: </strong>A single session of functional neurology significantly improved both genital thermoregulation and ejaculatory latency in men with PE. These find","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 3","pages":"qfaf046"},"PeriodicalIF":2.0,"publicationDate":"2025-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12296338/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144733071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Limitation to the capacity to love and hypersexual behavior in their relationship with psychoticism and paranoid ideation. 爱的能力限制和性欲亢进与精神病和偏执观念的关系。
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-07-25 eCollection Date: 2025-06-01 DOI: 10.1093/sexmed/qfaf050
Giulia Origlia, Davide Doroldi, Gabriele Lo Buglio, Tommaso Boldrini, Antonio Del Casale, Grazia Spitoni, Erika Limoncin, Giacomo Ciocca

Background: Limitation to the Capacity to Love (CTL) and problematic sexuality could be considered as indicators of psychopathological suffering.

Aim: We aimed to investigate the relationship between problematic sexuality, specifically hypersexuality, and the symptom dimensions of psychoticism and paranoid ideation, with a focus on the role of the CTL, in a non-clinical sample.

Methods: Through an online platform, we recruited a convenience sample of 521 subjects (390 females and 131 males; age span: 18-50).

Outcomes: Recruited subjects completed a psychometric protocol that included completion of the following measurement tools: (1) the Capacity to Love Inventory, (2) the Hypersexual Behavior Inventory, (3) the Brief Symptom Inventory.

Results: Results indicated a significant inverse correlation between CTL and both paranoid ideation and psychoticism, with hypersexuality positively correlated with these symptoms. Linear regression analysis revealed that CTL acts as a protective factor, while hypersexuality is a predictive factor for both psychoticism and paranoid ideation.

Clinical implications: The study highlights the importance of evaluating sexual behavior and subclinical symptomatology in non-clinical populations, and it underscores the potential role of CTL as an indicator of relational functioning.

Strengths and limitations: The strength of this research lies undoubtedly in its innovative inclusion of the construct of CTL in studying the relationship between sexuality, paranoid ideation, and psychoticism.However, the research design reveals a gender imbalance that may limit the significance of the findings. Moreover, the study was conducted on a sample primarily composed of students and individuals from Italian cultural backgrounds, which should be considered when generalizing the results.

Conclusion: The relationship between the limitation of the CTL, hypersexuality and paranoid ideation and psychoticism (assessed with the SCL-90) sheds light on the importance of integrating the assessment of a central aspect of human life, that is, the CTL, with problematic sexuality and psychopathological symptoms, in the clinical practice of prevention of sexual and psychological problems.

背景:爱的能力限制(CTL)和性问题可以被认为是精神病理痛苦的指标。目的:我们旨在调查问题性行为,特别是性欲亢进,与精神病和偏执观念的症状维度之间的关系,重点关注CTL在非临床样本中的作用。方法:通过网络平台,我们招募了521名受试者(女性390人,男性131人;年龄:18-50岁。结果:招募的受试者完成了一项心理测量方案,包括完成以下测量工具:(1)爱的能力量表,(2)性欲亢进行为量表,(3)简短症状量表。结果:CTL与偏执妄想和精神病呈显著负相关,而性欲亢进与偏执妄想和精神病呈显著正相关。线性回归分析显示,CTL是保护因子,而性欲亢进是精神病和偏执妄想的预测因子。临床意义:该研究强调了在非临床人群中评估性行为和亚临床症状的重要性,并强调了CTL作为关系功能指标的潜在作用。优势与局限:本研究的优势无疑在于其创新性地纳入了CTL的结构来研究性、偏执观念和精神病之间的关系。然而,研究设计揭示了性别失衡,这可能会限制研究结果的意义。此外,该研究的样本主要由来自意大利文化背景的学生和个人组成,在推广结果时应考虑到这一点。结论:CTL的局限性、性欲亢进、偏执观念和精神病(用SCL-90评估)之间的关系揭示了将人类生活的一个核心方面,即CTL、性问题和精神病理症状的评估整合在性和心理问题预防的临床实践中的重要性。
{"title":"Limitation to the capacity to love and hypersexual behavior in their relationship with psychoticism and paranoid ideation.","authors":"Giulia Origlia, Davide Doroldi, Gabriele Lo Buglio, Tommaso Boldrini, Antonio Del Casale, Grazia Spitoni, Erika Limoncin, Giacomo Ciocca","doi":"10.1093/sexmed/qfaf050","DOIUrl":"10.1093/sexmed/qfaf050","url":null,"abstract":"<p><strong>Background: </strong>Limitation to the Capacity to Love (CTL) and problematic sexuality could be considered as indicators of psychopathological suffering.</p><p><strong>Aim: </strong>We aimed to investigate the relationship between problematic sexuality, specifically hypersexuality, and the symptom dimensions of psychoticism and paranoid ideation, with a focus on the role of the CTL, in a non-clinical sample.</p><p><strong>Methods: </strong>Through an online platform, we recruited a convenience sample of 521 subjects (390 females and 131 males; age span: 18-50).</p><p><strong>Outcomes: </strong>Recruited subjects completed a psychometric protocol that included completion of the following measurement tools: (1) the Capacity to Love Inventory, (2) the Hypersexual Behavior Inventory, (3) the Brief Symptom Inventory.</p><p><strong>Results: </strong>Results indicated a significant inverse correlation between CTL and both paranoid ideation and psychoticism, with hypersexuality positively correlated with these symptoms. Linear regression analysis revealed that CTL acts as a protective factor, while hypersexuality is a predictive factor for both psychoticism and paranoid ideation.</p><p><strong>Clinical implications: </strong>The study highlights the importance of evaluating sexual behavior and subclinical symptomatology in non-clinical populations, and it underscores the potential role of CTL as an indicator of relational functioning.</p><p><strong>Strengths and limitations: </strong>The strength of this research lies undoubtedly in its innovative inclusion of the construct of CTL in studying the relationship between sexuality, paranoid ideation, and psychoticism.However, the research design reveals a gender imbalance that may limit the significance of the findings. Moreover, the study was conducted on a sample primarily composed of students and individuals from Italian cultural backgrounds, which should be considered when generalizing the results.</p><p><strong>Conclusion: </strong>The relationship between the limitation of the CTL, hypersexuality and paranoid ideation and psychoticism (assessed with the SCL-90) sheds light on the importance of integrating the assessment of a central aspect of human life, that is, the CTL, with problematic sexuality and psychopathological symptoms, in the clinical practice of prevention of sexual and psychological problems.</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 3","pages":"qfaf050"},"PeriodicalIF":2.0,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12291535/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144733070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship and sexual satisfaction among patients with bipolar disorder and partners. 双相情感障碍患者及其伴侣的关系和性满意度。
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-07-22 eCollection Date: 2025-06-01 DOI: 10.1093/sexmed/qfaf051
Lærke Helene Andreasen, Vita Djamilla Sandeman, Helle B Krogh, Julie Ravneberg Stokholm, Caroline Fussing Bruun, Jeff Zarp, Lars Vedel Kessing, Annamaria Giraldi, Maj Vinberg

Objectives: Good interpersonal relationships are associated with improved functioning, quality of life, and a better prognosis in patients with bipolar disorder (BD). Little information is available regarding relationship satisfaction and sexual satisfaction within couples where 1 partner has BD.

Aim: This cross-sectional study aimed to examine relationship and sexual satisfaction in patients with BD and partners to patients with BD.

Methods: Patients with BD and partners to patients with BD were included, and outcomes were assessed using semi-structured interviews and questionnaires.

Outcomes: Couple satisfaction was measured by the self-reported questionnaire Couple Satisfaction Index (CSI-4), and sexual satisfaction was measured by 3 self-reported questions. Multiple regression analyses were used to compare the groups adjusting for sex, age, mood symptoms, overall functioning, and stress symptoms. The results were compared to general populations.

Results: One hundred eleven patients with BD and 74 partners were included. We found a significant difference between patients with BD and partners concerning relationship satisfaction measured with the CSI, with partners being less satisfied (P = .050). Comparing relationship satisfaction in patients with BD and partners to the general population, we found that the general population was more satisfied in each CSI item (P < .050). In multiple regression analyses adjusted for sex, age, mood symptoms, stress, and function, patients with BD were more satisfied with their sexual life over the last year compared to partners (P = .039). They further rated the importance of a good sexual life higher than partners (P = .006). Finally, more patients with BD and partners rated their sex life the last year as being bad to extremely bad compared to the control group from the general population (partners = 21.1%, BD = 23.4%, general population = 16%).

Clinical implications: In clinical practice, it is essential to focus on relationships including sexual life in patients with BD and partners as both groups have a lower degree of relationship and sexual satisfaction compared to the general population.

Strengths and limitations: The use of validated questionnaires and clinical ratings is a strength, albeit the cross-sectional design is a limitation.

Conclusions: Patients with BD reported a higher degree of satisfaction with their relationship and sexual life compared to their partners. Compared to the general population, both groups expressed lower degree of relationship and sexual satisfaction.

目的:良好的人际关系与改善双相情感障碍(BD)患者的功能、生活质量和更好的预后有关。关于一方患有双相障碍的夫妻关系满意度和性满意度的信息很少。目的:本横断面研究旨在检查双相障碍患者及其伴侣的关系和性满意度。方法:包括双相障碍患者和双相障碍患者的伴侣,并通过半结构化访谈和问卷调查评估结果。结果:夫妻满意度采用自述问卷夫妻满意度指数(CSI-4)测量,性满意度采用3个自述问题测量。采用多元回归分析比较各组的性别、年龄、情绪症状、整体功能和压力症状。研究结果与一般人群进行了比较。结果:纳入111例BD患者和74例伴侣。我们发现,在用CSI测量的关系满意度方面,BD患者和伴侣之间存在显著差异,伴侣满意度较低(P = 0.050)。将BD患者和伴侣的关系满意度与普通人群进行比较,我们发现普通人群在CSI的每个项目上都更满意(P P = .039)。他们进一步认为良好的性生活比伴侣更重要(P = 0.006)。最后,与普通人群的对照组相比,更多的双相障碍患者和伴侣认为他们去年的性生活不好到极差(伴侣= 21.1%,双相障碍= 23.4%,普通人群= 16%)。临床意义:在临床实践中,关注双相障碍患者和伴侣的关系包括性生活是至关重要的,因为与一般人群相比,双相障碍患者和伴侣的关系程度和性满意度都较低。优势和局限性:使用有效的问卷调查和临床评分是一个优势,尽管横断面设计是一个局限性。结论:与他们的伴侣相比,BD患者对他们的关系和性生活的满意度更高。与一般人群相比,这两个群体的关系程度和性满意度都较低。
{"title":"Relationship and sexual satisfaction among patients with bipolar disorder and partners.","authors":"Lærke Helene Andreasen, Vita Djamilla Sandeman, Helle B Krogh, Julie Ravneberg Stokholm, Caroline Fussing Bruun, Jeff Zarp, Lars Vedel Kessing, Annamaria Giraldi, Maj Vinberg","doi":"10.1093/sexmed/qfaf051","DOIUrl":"10.1093/sexmed/qfaf051","url":null,"abstract":"<p><strong>Objectives: </strong>Good interpersonal relationships are associated with improved functioning, quality of life, and a better prognosis in patients with bipolar disorder (BD). Little information is available regarding relationship satisfaction and sexual satisfaction within couples where 1 partner has BD.</p><p><strong>Aim: </strong>This cross-sectional study aimed to examine relationship and sexual satisfaction in patients with BD and partners to patients with BD.</p><p><strong>Methods: </strong>Patients with BD and partners to patients with BD were included, and outcomes were assessed using semi-structured interviews and questionnaires.</p><p><strong>Outcomes: </strong>Couple satisfaction was measured by the self-reported questionnaire Couple Satisfaction Index (CSI-4), and sexual satisfaction was measured by 3 self-reported questions. Multiple regression analyses were used to compare the groups adjusting for sex, age, mood symptoms, overall functioning, and stress symptoms. The results were compared to general populations.</p><p><strong>Results: </strong>One hundred eleven patients with BD and 74 partners were included. We found a significant difference between patients with BD and partners concerning relationship satisfaction measured with the CSI, with partners being less satisfied (<i>P</i> = .050). Comparing relationship satisfaction in patients with BD and partners to the general population, we found that the general population was more satisfied in each CSI item (<i>P</i> < .050). In multiple regression analyses adjusted for sex, age, mood symptoms, stress, and function, patients with BD were more satisfied with their sexual life over the last year compared to partners (<i>P</i> = .039). They further rated the importance of a good sexual life higher than partners (<i>P</i> = .006). Finally, more patients with BD and partners rated their sex life the last year as being bad to extremely bad compared to the control group from the general population (partners = 21.1%, BD = 23.4%, general population = 16%).</p><p><strong>Clinical implications: </strong>In clinical practice, it is essential to focus on relationships including sexual life in patients with BD and partners as both groups have a lower degree of relationship and sexual satisfaction compared to the general population.</p><p><strong>Strengths and limitations: </strong>The use of validated questionnaires and clinical ratings is a strength, albeit the cross-sectional design is a limitation.</p><p><strong>Conclusions: </strong>Patients with BD reported a higher degree of satisfaction with their relationship and sexual life compared to their partners. Compared to the general population, both groups expressed lower degree of relationship and sexual satisfaction.</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 3","pages":"qfaf051"},"PeriodicalIF":2.0,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12282118/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144691416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Sexual Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1